Grup de recerca translacional vascular i renal
Responsable de grup
Publicacions (443)
Bermudez-Lopez M; Perpiñan H; Amigo N; Castro E; Alonso N; Mauricio D; Fernandez E; Valdivielso JM
Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients.
Clinical Kidney Journal 14 2591-2599. .
Solache-Berrocal G; Rolle-Sóñora V; Martín-Fernández N; Cambray S; Valdivielso JM; Rodríguez I
CYP24A1 and KL polymorphisms are associated with the extent of vascular calcification but do not improve prediction of cardiovascular events.
NEPHROLOGY DIALYSIS TRANSPLANTATION 36 2076-2083. .
Del Carpio, J; Marco, MP; Martin, ML; Craver, L; Jatem, E; Gonzalez, J; Chang, P; Ibarz, M; Pico, S; Falcon, G; Canales, M; Huertas, E; Romero, I; Nieto, N; Segarra, A
External validation of the Madrid Acute Kidney Injury Prediction Score
Clinical Kidney Journal 14 2377-2382. .
Caus M; Eritja À; Bozic M
Role of microRNAs in Obesity-Related Kidney Disease.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. .
Valdivielso JM; Balafa O; Ekart R; Ferro CJ; Mallamaci F; Mark PB; Rossignol P; Sarafidis P; Del Vecchio L; Ortiz A
Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.
DRUGS 81 1819-1819. .
Castelblanco E; Sarrias MR; Betriu À; Soldevila B; Barranco-Altirriba M; Franch-Nadal J; Valdivielso JM; Bermudez-Lopez M; Groop PH; Fernández E; Alonso N; Mauricio D
Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.
Aging-US 13 22690-22709. .
Alonso-Perez E; Forné C; Soro M; Valls M; Manganelli AG; Valdivielso JM
Health Care Costs in Patients with and without Secondary Hyperparathyroidism in Spain.
ADVANCES IN THERAPY 38 5333-5344. .
Granado-Casas M; Martinez-Gonzalez D; Martínez-Alonso M; Dòria M; Alcubierre N; Valls J; Julve J; Verdú-Soriano J; Mauricio D
Psychometric Validation of the Cardiff Wound Impact Schedule Questionnaire in a Spanish Population with Diabetic Foot Ulcer.
Journal of Clinical Medicine 10 -. .
Benítez, I; Carratalá, A; Moncusí-Moix, A; Gort-Paniello, C; Pinilla, L; Molinero, M; González, J; Torres, G; Bernal, M; Pico, S; Almansa, R; Jorge, N; Ortega, A; Bustamante-Munguira, E; Gómez, JM; González-Rivera, M; Micheloud, D; Ryan, P; Martínez, A; Tamayo, L; Aldecoa, C; Ferrer, R; Ceccato, A; Fernández, L; Motos, A; Riera, J; Menéndez, R; Garcia-Gasulla, D; Penuelas, O; Torres, A; Bermejo-Martin, JF; Barbé, F; Calvo, DD
Potential translation of plasma microRNA signatures in the risk stratification of COVID-19 patients admitted to the ICU
EUROPEAN RESPIRATORY JOURNAL 58 -. .
Mota-Zamorano S; Robles NR; González LM; Valdivielso JM; Lopez-Gomez J; Cancho B; García-Pino G; Gervasini G
Genetics Variants in the Epoxygenase Pathway of Arachidonic Metabolism Are Associated with Eicosanoids Levels and the Risk of Diabetic Nephropathy.
Journal of Clinical Medicine 10 -. .
Valdivielso, JM; Balafa, O; Ekart, R; Ferro, CJ; Mallamaci, F; Mark, PB; Rossignol, P; Sarafidis, P; del Vecchio, L; Ortiz, A
Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
DRUGS 81 1467-1489. .
Buxeda, A; Arias-Cabrales, C; Perez-Saez, MJ; Cacho, J; Pelegrin, SC; Melilli, E; Aladren, MJ; Galeano, C; Lorenzo, I; Mazuecos, A; Saura, IM; Franco, A; Ruiz-Fuentes, MD; Sanchez-Camara, LA; Siverio, O; Martin, ML; Gonzalez-Garcia, E; Lopez, V; Martin-Moreno, PL; Moina, I; Berrio, EM; Moreso, F; Portoles, JM; Santana-Estupinan, R; Zarraga, S; Canal, C; Sanchez-Alvarez, E; Pascual, J; Crespo, M
Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
Kidney International Reports 6 2305-2315. .